Ainara Estanga

San Sebastian, PV 20009, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Neuropsychiatric signatures across the Alzheimer's disease continuum in Down syndrome and sporadic forms: A biomarker-driven comparison.

Neuropsychiatric signatures across the Alzheimer's disease continuum in Down syndrome and sporadic forms: A biomarker-driven comparison.

Journal: Journal of Alzheimer's disease : JAD

Published: December 31, 2025

Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.

Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study.

Journal: Lancet (London, England)

Published: October 31, 2025

Cognitive Age Delta as a Marker of Healthy and Pathological Cognitive Aging: The Role of Lifestyle, Cognitive Reserve, and Vascular Risk.

Cognitive Age Delta as a Marker of Healthy and Pathological Cognitive Aging: The Role of Lifestyle, Cognitive Reserve, and Vascular Risk.

Journal: Journal of clinical medicine

Published: October 12, 2025

Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.

Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: September 11, 2025

Preclinical Alzheimer's and vascular biomarkers alter brain aging in cognitively normal adults: a MRI-based study.

Preclinical Alzheimer's and vascular biomarkers alter brain aging in cognitively normal adults: a MRI-based study.

Journal: Frontiers in aging neuroscience

Published: June 24, 2025

Stepwise approach to alzheimer's disease diagnosis in primary care using cognitive screening, risk factors, neuroimaging and plasma biomarkers.

Stepwise approach to alzheimer's disease diagnosis in primary care using cognitive screening, risk factors, neuroimaging and plasma biomarkers.

Journal: Scientific reports

Published: May 29, 2025

Development of amyloid-negative neuropsychological norms using GAMLSS.

Development of amyloid-negative neuropsychological norms using GAMLSS.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: March 12, 2025

Prevalence and Misperception: Exploring the Gap Between Objective and Subjective Assessment of Sleep Apnea in a Population at Increased Risk for Dementia.

Prevalence and Misperception: Exploring the Gap Between Objective and Subjective Assessment of Sleep Apnea in a Population at Increased Risk for Dementia.

Journal: Journal of clinical medicine

Published: January 27, 2025

CITA GO-ON study. A community based multidomain lifestyle intervention to prevent cognitive decline. Protocol design and recruitment process.

CITA GO-ON study. A community based multidomain lifestyle intervention to prevent cognitive decline. Protocol design and recruitment process.

Journal: Frontiers in aging neuroscience

Published: December 04, 2024

Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study.

Decreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort study.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 04, 2024

Unlocking Preclinical Alzheimer's: A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics.

Unlocking Preclinical Alzheimer's: A Multi-Year Label-Free In Vitro Raman Spectroscopy Study Empowered by Chemometrics.

Journal: International journal of molecular sciences

Published: April 08, 2024

Down Syndrome-Basque Alzheimer Initiative (DS-BAI): Clinic-Biological Cohort.

Down Syndrome-Basque Alzheimer Initiative (DS-BAI): Clinic-Biological Cohort.

Journal: Journal of clinical medicine

Published: January 14, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026